Transdermal therapeutic formulation containing a limonene
US5164416A · kind A · utility
42Cited by
10References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 1991 |
| Grant date | Nov 17, 1992 |
| Priority date | — |
| Expiry date | May 8, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transdermal therapeutic formulation comprising d-limonene and at least one pharmaceutically active substance wherein the content of the d-limonene is in the range from 0.1 to 2 weight percent, based on the total amount of the formulation. The transdermal therapeutic formulation has an excellent percutaneous absorption, is safe and is capable of delivering desired pharmaceutically active substances to a desired location of treatment or to the entire body of a patient through the circulatory system and is thus effective for curing various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.